Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer
2003921 citationsJames F. Holland, Emil Frei et al.Journal of Clinical Oncologyprofile →
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
1990882 citationsEmil Frei et al.New England Journal of Medicineprofile →
Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide
1960865 citationsEmil Frei, Clyde O. Brindley et al.profile →
This map shows the geographic impact of Emil Frei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emil Frei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emil Frei more than expected).
This network shows the impact of papers produced by Emil Frei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emil Frei. The network helps show where Emil Frei may publish in the future.
Co-authorship network of co-authors of Emil Frei
This figure shows the co-authorship network connecting the top 25 collaborators of Emil Frei.
A scholar is included among the top collaborators of Emil Frei based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Emil Frei. Emil Frei is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Antman, Karen, James D. Griffin, Anthony Elias, et al.. (1988). Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression. New England Journal of Medicine. 319(10). 593–598.538 indexed citations breakdown →
10.
Israel, Mervyn, P M Wilkinson, William J. Pegg, & Emil Frei. (1978). Hepatobiliary metabolism and excretion of adriamycin and N-trifluoroacetyladriamycin-14-valerate in the rat.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(2). 365–70.41 indexed citations
11.
Krishan, Awtar, Mervyn Israel, Edward J. Modest, & Emil Frei. (1976). Differences in cellular uptake and cytofluorescence of adriamycin and N-trifluoroacetyladriamycin-14-valerate.. PubMed. 36(6). 2108–9.53 indexed citations
12.
Krishan, Awtar, et al.. (1976). Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(10). 3813–20.30 indexed citations
13.
Krishan, Awtar & Emil Frei. (1975). Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(3). 497–501.43 indexed citations
14.
Livingston, R. B., Gerald P. Bodey, Jeffrey A. Gottlieb, & Emil Frei. (1973). Kinetic scheduling of vincristine (NSC-67574) and bleomycin (NSC-125066) in patients with lung cancer and other malignant tumors.. PubMed. 57(2). 219–24.31 indexed citations
15.
Frei, Emil. (1965). Summary of Informal Discussion on Clinical Obstacles to the Control of Leukemia. Cancer Research. 25. 1510–1510.2 indexed citations
16.
Bono, Vincent H., C. C. Cheng, Emil Frei, & Margaret G. Kelly. (1964). MEHTYL-5-FLUOROOROTATE: SYNTHESIS AND COMPARISON WITH 5-FLUOROOROTIC ACID WITH RESPECT TO BIOLOGICAL ACTIVITY AND CELL ENTRY.. PubMed. 24. 513–7.6 indexed citations
Shnider, Bruce I., Emil Frei, John G. Gorman, et al.. (1960). Clinical Studies of 6-Azauracil. Cancer Research. 20(1). 28–33.31 indexed citations
20.
Brindley, Clyde O., Jacob Colsky, Margarida M. Dederick, et al.. (1960). Clinical Trial of the Cytostatic Agent A-139 (2,5-Bis[1-Aziridinyl]-3,6-bis[2-methoxyethoxy]-p-benzoquinone). Cancer Research. 20(11). 1580–1583.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.